148 related articles for article (PubMed ID: 17640058)
1. Polymorphisms in PTGS1, PTGS2 and IL-10 do not influence colorectal adenoma recurrence in the context of a randomized aspirin intervention trial.
Hubner RA; Muir KR; Liu JF; Logan RFA; Grainge MJ; Houlston RS;
Int J Cancer; 2007 Nov; 121(9):2001-2004. PubMed ID: 17640058
[TBL] [Abstract][Full Text] [Related]
2. PTGS2 (COX-2) -765G > C promoter variant reduces risk of colorectal adenoma among nonusers of nonsteroidal anti-inflammatory drugs.
Ulrich CM; Whitton J; Yu JH; Sibert J; Sparks R; Potter JD; Bigler J
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):616-9. PubMed ID: 15767339
[TBL] [Abstract][Full Text] [Related]
3. Dairy products, polymorphisms in the vitamin D receptor gene and colorectal adenoma recurrence.
Hubner RA; Muir KR; Liu JF; Logan RF; Grainge MJ; Houlston RS;
Int J Cancer; 2008 Aug; 123(3):586-93. PubMed ID: 18470879
[TBL] [Abstract][Full Text] [Related]
4. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
[TBL] [Abstract][Full Text] [Related]
5. CYP2C9 variants increase risk of colorectal adenoma recurrence and modify associations with smoking but not aspirin treatment.
Barry EL; Poole EM; Baron JA; Makar KW; Mott LA; Sandler RS; Ahnen DJ; Bresalier RS; McKeown-Eyssen GE; Ulrich CM
Cancer Causes Control; 2013 Jan; 24(1):47-54. PubMed ID: 23081681
[TBL] [Abstract][Full Text] [Related]
6. Cyclooxygenase-2 polymorphisms, aspirin treatment, and risk for colorectal adenoma recurrence--data from a randomized clinical trial.
Barry EL; Sansbury LB; Grau MV; Ali IU; Tsang S; Munroe DJ; Ahnen DJ; Sandler RS; Saibil F; Gui J; Bresalier RS; McKeown-Eyssen GE; Burke C; Baron JA
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2726-33. PubMed ID: 19755647
[TBL] [Abstract][Full Text] [Related]
7. COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations.
Makar KW; Poole EM; Resler AJ; Seufert B; Curtin K; Kleinstein SE; Duggan D; Kulmacz RJ; Hsu L; Whitton J; Carlson CS; Rimorin CF; Caan BJ; Baron JA; Potter JD; Slattery ML; Ulrich CM
Cancer Causes Control; 2013 Dec; 24(12):2059-75. PubMed ID: 24022467
[TBL] [Abstract][Full Text] [Related]
8. Cytokine gene polymorphisms, cytokine levels and the risk of colorectal neoplasia in a screened population of Northeast Scotland.
Basavaraju U; Shebl FM; Palmer AJ; Berry S; Hold GL; El-Omar EM; Rabkin CS
Eur J Cancer Prev; 2015 Jul; 24(4):296-304. PubMed ID: 25350634
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in PTGS1 (=COX-1) and risk of colorectal polyps.
Ulrich CM; Bigler J; Sparks R; Whitton J; Sibert JG; Goode EL; Yasui Y; Potter JD
Cancer Epidemiol Biomarkers Prev; 2004 May; 13(5):889-93. PubMed ID: 15159324
[TBL] [Abstract][Full Text] [Related]
10. Association between PTGS1 polymorphisms and functional outcomes in Chinese patients with stroke during aspirin therapy: Interaction with smoking.
Cai H; Cai B; Sun L; Zhang H; Zhou S; Cao L; Guo H; Sun W; Yan B; Davis SM; Zhang Z; Liu X
J Neurol Sci; 2017 May; 376():211-215. PubMed ID: 28431615
[TBL] [Abstract][Full Text] [Related]
11. Effect of PEAR1, PTGS1 gene polymorphisms on the recurrence of aspirin-treated patients with ischemic stroke in the Han population of China: A 4-year follow-up study.
Zhang L; Meng Z; Wang H; Miao Y
Medicine (Baltimore); 2024 May; 103(19):e38031. PubMed ID: 38728491
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict Colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
Davies JR; Mell T; Fuller H; Harland M; Saleh RNM; Race AD; Rees CJ; Brown LC; Loadman PM; Downing A; Minihane AM; Williams EA; Hull MA
Cancer Prev Res (Phila); 2023 Nov; 16(11):621-629. PubMed ID: 37756582
[TBL] [Abstract][Full Text] [Related]
13. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.
Chan AT; Hsu M; Zauber AG; Hawk ET; Bertagnolli MM
Cancer Prev Res (Phila); 2012 Jan; 5(1):61-72. PubMed ID: 22030088
[TBL] [Abstract][Full Text] [Related]
14. Chemoprevention of colorectal cancer: systematic review and economic evaluation.
Cooper K; Squires H; Carroll C; Papaioannou D; Booth A; Logan RF; Maguire C; Hind D; Tappenden P
Health Technol Assess; 2010 Jun; 14(32):1-206. PubMed ID: 20594533
[TBL] [Abstract][Full Text] [Related]
15. Prostaglandin H synthase 2 variant (Val511Ala) in African Americans may reduce the risk for colorectal neoplasia.
Lin HJ; Lakkides KM; Keku TO; Reddy ST; Louie AD; Kau IH; Zhou H; Gim JS; Ma HL; Matthies CF; Dai A; Huang HF; Materi AM; Lin JH; Frankl HD; Lee ER; Hardy SI; Herschman HR; Henderson BE; Kolonel LN; Le Marchand L; Garavito RM; Sandler RS; Haile RW; Smith WL
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1305-15. PubMed ID: 12433707
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of PTGS1 and PTGS2 polymorphisms and NSAID intake on the risk of developing cancer.
Nagao M; Sato Y; Yamauchi A
PLoS One; 2013; 8(8):e71126. PubMed ID: 23967159
[TBL] [Abstract][Full Text] [Related]
17. The role of cytokine gene polymorphisms in colorectal cancer and their interaction with aspirin use in the northeast of Scotland.
Macarthur M; Sharp L; Hold GL; Little J; El-Omar EM
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1613-8. PubMed ID: 16030091
[TBL] [Abstract][Full Text] [Related]
18. Effects of aspirin and non-aspirin nonsteroidal anti-inflammatory drugs on the incidence of recurrent colorectal adenomas: a systematic review with meta-analysis and trial sequential analysis of randomized clinical trials.
Veettil SK; Lim KG; Ching SM; Saokaew S; Phisalprapa P; Chaiyakunapruk N
BMC Cancer; 2017 Nov; 17(1):763. PubMed ID: 29137605
[TBL] [Abstract][Full Text] [Related]
19. Genetic polymorphisms in the cyclooxygenase-1 and cyclooxygenase-2 genes and risk of colorectal adenoma.
Gong Z; Bostick RM; Xie D; Hurley TG; Deng Z; Dixon DA; Zhang J; Hebert JR
Int J Colorectal Dis; 2009 Jun; 24(6):647-54. PubMed ID: 19205707
[TBL] [Abstract][Full Text] [Related]
20. Influence of cyclooxygenase-1 genotype on ex vivo aspirin response in patients at risk for stroke.
Momary KM; Shapiro NL; Brace LD; Shord SS; Grossi E; Viana MA; Helgason CM; Nutescu EA; Cavallari LH
Cerebrovasc Dis; 2009; 27(6):585-93. PubMed ID: 19390185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
